- 1) Heinegård, D., Hultenby, K., Oldberg, Å., Reinholt, F., and Wendel, M., Macromolecules in bone matrix. Connect. Tissue Res., 21, 3-14 (1989).
- 2) Ohnishi, T., Arakaki, N., Nakamura, O., Hirono, S., and Daikuhara, Y., Purification, characterization, and studies on biosynthesis of a 59-kDa bone sialic acid-containing protein (BSP) from rat mandible using a monoclonal antibody. Evidence that 59-kDa BSP may be the rat counterpart of human α2-HS glycoprotein and is synthesized by both hepatocyte and osteoblasts. J. Biol. Chem., 266, 14636-1464 (1991).
- 3) Ohnishi, T., Nakamura, O., Ozawa, M., Arakaki, N., Muramatsu, T., and Daikuhara, Y., Molecular cloning and sequence analysis of cDNA for a 59-kD bone sialoprotein of the rat: Demonstration that it is a counterpart of human α2-HS glycoprotein and bovine fetuin. J. Bone Miner. Res., 8, 367-377 (1993).
- 4) Arnaud, P., Miribel, L., and Emerson, D. L., α2-HS glycoprotein. Method. Enzymol., 163, 431-444 (1988).
- 5) Kellerman, J., Haupt, H., Auerswald, E.-A., and Müller-Esterl, W., The arrangement of disulfide loops in human α2-HS glycoprotein. Similarity to the disulfide bridge structures of cystatins and kininogens. J. Biol. Chem., 264, 14121-14128 (1989).
- 6) Hu, B., Coulson, L., Moyer, B., and Price, P. A., Isolation and molecular cloning of a novel bone phosphoprotein related in sequence to the cystatin family of thiol protease inhibitors. J. Biol. Chem., 270, 431-436 (1995).
- 7) Haaseman, M., Nawratil, P., and Müller-Esterl, W., Rat tyrosine kinase inhibitor shows sequence similarity to human α2-HS glycoprotein and bovine fetuin. Biochem. J., 274, 899-902 (1991).
- 8) Rauth, G., Pöchke, O., Fink, E., Eulitz, M., Tippmer, S., Kellerer, M., Häring, H.-U., Nawratil, P., Hassemann, M., Jahnen-Dechent, W., and Müller-Esterl, W., The nucleotide and partial amino acid sequences of the rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor. Eur. J. Biochem., 204, 523-529 (1992).
- 9) Auberger, P., Falquerho, L., Contreres, J. O., Pages, G., Le Cam, G., Rossi, B., and Le Cam, A., Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and antimitogenic activity. Cell, 58, 631-640 (1989).
- . 1993. p. 251- 274.
- 11) Ohnishi, T., Nakamura, O., Arakaki, N., and Daikuhara, Y., Effect of phosphorylated rat fetuin on the growth of hepatocyte in primary culture in the presence of hepatocyte growth factor-scatter factor (HGF/SF). Evidence that phosphorylated rat fetuin is a natural modulator of HGF/SF. Eur. J. Biochem., 243, 753-761 (1997).
- 12) Rohrlich, S. T. and Rifkin, D. B., Isolation of the major serine protease inhibitor from the 5-day serum-free conditioned medium of human embryonic lung cells and demonstration that it is fetuin. J. Cell Physil., 109, 1-15 (1981).
- 13) Hsu, C. C. S. and Floyd, M., Lymphocyte stimulating and immunochemical properties of fetuin preparations. Protides Biol. Fluids Proc. Colloq., 24, 295-302 (1976).
- 14) Cayatte, A. J., Kumbla, L., and Subbiah, M. T. R., Marked acceleration of exogenous fatty acid incorporation into cellular triglyceride by fetuin. J. Biol. Chem., 265, 5883-5888 (1990).
- 15) Kumbla, L., Cayatte, A. J., and Subbiah, M. T. R., Association of a lipoprotein-like particle with bovine fetuin. FASEB J., 3, 2075-2080 (1989).
- 16) Fisher, D. A. and Lam, R. W., Thyroid hormone binding by bovine and ovine fetuin. Endocrinology, 94, 49-54 (1974).
- 17) Abdullah, M., Crowell, J. A., Tres, L. L., and Kierszenbaum, A. L., Fetuin: A serum component associated with rat Sertoli and spermatogenic cells in coculture. J. Cell Physiol., 127, 463-472 (1986).
- 18) Triffitt, J. T., Gebauer, U., Ashton, B. A., Owen, M. E., and Reynolds J. J., Origin of plasma α2-HS glycoprotein and its accumulation in bone. Nature, 262, 226-227 (1976).
- 19) Schinke, T., Amendt, C., Trindl, A., Pöschke, O., Müller-Esterl, W., and Jahnen-Dechent, W., The serum protein α2-HS Glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. J. Biol. Chem., 271, 20789-20796 (1996).
- 20) Wilson, J. M., Ashton, B. A., and Triffitt, J. T., The interaction of a component of bone organic matrix with the mineral phase. Calcif. Tissue Int., 22, 458-460 (1977).
- 21) Demetriou, M., Binkert, C., Sukhu, B., Tenenbaum, H. C., and Dennis, J. W., Fetuin/α2-HS glycoprotein is a transforming growth factor-β type II receptor mimic and cytokine antagonist. J. Biol. Chem., 271, 12755-12761 (1996).
- 22) Yang, F., Schwartz, Z., Swain, L. D., Lee, C.-C., Bowman, B. H., and Boyan B. D., α2-HS glycoprotein: Expression in chondrocytes and augmentation of alkaline phosphatase and phospholipase A2 activity. Bone, 12, 7-15 (1991).
- 23) Malone, J. D., Teitelbaum, S. L., Griffin, G. L., Senior, R. M., and Kahn, A. J. Recruitment of osteoclast precursors by purified bone matrix constituents. J. Cell Biol., 92, 227-230 (1982).
- 24) Colclasure , G. C., Lloyd, W. S., Lamkin, M., Gonnerman, W., Troxler, R. F., Offner, G. D., Bürgi, W., Schmid, K., and Nimberg, R. B., Human serum α2-HS glycoprotein modulates in vitro bone resorption. J. Clin. Endocrin. Metabol., 66, 187-192 (1987).
- 25) Nakamura, O., Gohda, E., Ozawa., M, Senba, I., Miyazaki, H., Murakami, T., and Daikuhara, Y., Immunohistochemical studies with a monoclonal antibody on the distribution of phosphophoryn in predentin and dentin. Calcif. Tissue Int., 37, 491-500 (1985).
- 26) Nakama, T., Nakamura, O., Daikuhara, Y., and Semba, T., A monoclonal antibody against dentin phosphophoryn recognizes a bone protein(s) appearing at the beginning of ossification. Calcif. Tissue Int., 43, 263-267 (1988).
- 27) Shiina, Y., Yamaguchi, A., Yamana, H., Abe, E., Yoshiki, S., Suda, T., Comparison of the mechanism of bone resorption induced by 1α, 25-dihydroxyvitamin D3 and lipopolysaccharides. Calcif. Tissue Int., 39, 28-34 (1986).
- 28) Kakegawa, H., Nikawa, T., Tagami, K., Kamioka, H., Sumitani, K., Kawata, T., Drobnic-Kosorok, M., Lenarcic, B., Turk, V., and Katunuma, N., Participation of cathepsin L on bone resorption. FEBS Lett., 321, 247-250 (1993).
- 29) Barrett, A. J. and Kirschke, H., Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol., 80, 535-561 (1981).
- . 1967. p. 1- 593.
- 31) Vaes, G., A review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin. Orthop. Related Res., 231, 239-271 (1988).
- 32) Roodman, G. D., Interleukin-6: An osteotropic factor? J. Bone Miner. Res., 7, 475-478 (1992).
- 33) Barton, B. E. and Mayer, R., IL 3 and IL 6 do not induce bone resorption in vitro. Cytokine, 2, 217-220 (1990).
- 34) Al-Humidan, A., Ralston, S. H., Hughes, D. E., Chapman, K., Aarden, L., Russell, R. G. G., and Gowen, M., Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. J. Bone Miner. Res., 6, 3-8 (1991).
- 35) Delaisse, J. M., Ledent, P., and Vaes, G., Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase. Biochem. J., 279, 167-174 (1991).
- 36) Goto, T., Kiyoshima, T., Moroi, R., Tsukuba T., Nishimura, Y., Himeno, M., Yamamoto, K., and Tanaka, T., Localization of cathepsins B, D, and L in the rat osteoclast by immune-light and -electron microscopy. Histochemistry, 101, 33-40 (1994).
- 37) Goto, T., Tsukuba, T., Kiyoshima, T., Nishimura, Y., Kato, K., Yamamoto, K., and Tanaka, T., Immunohistochemical localization of cathepsins B, D, L in the rat osteoclasts. Histochemistry, 99, 411-414 (1993).
- 38) Hill, P. A., Buttle, D. J., Jones, S. J., Boyde, A., Murata, M., Reynold, J. J., and Meikle, M. C., Inhibition of bone resorption by selective inactivators of cysteine proteinases. J. Cell Biochem., 56, 118-130 (1994).
- . 1994. p. 3- 21.
- . 1977. p. 249- 283.
- . 1980.
- 42) Welgus, H. G., Jeffrey, J. J., and Eisen, A. Z., The collagen substrate specificity of human skin fibroblast collagenase. J. Biol. Chem., 256, 9511-9515 (1981).
- 43) Lamkin, M. S., Colclasure, C., Lloyd, J. M., Gonerman, W., Schmid, K., and Nimberg, R. B., Purification and partial characterization of a 52,000 dalton glycoprotein from human cancer ascites fluid which stimulates bone resorption in vitro. Cancer Res., 46, 4650-4655 (1986).
- 44) Lamkin, M., Colclasure, C., Rodrick, M., Troxler, R. M., Offner, G. D., Lloyd, W. S., Schmid, K., and Nimberg, R. B., Three forms of BRF-2 (Bone Resorptive Proteins) from human cancer asites fluid and their relationship to human serum alpha-2 HS-glycoprotein. Calcif. Tissue Int., 41, 171-175 (1987).
- 45) Christie, D. L., Dziegielewska, K. M., Hill, R. M., and Saunders, N. R., Fetuin: the bovine homologue of human α2-HS glycoprotein. FEBS Lett., 214, 45-49 (1987).
- 46) Dziegielewska, K. M., Brown, W. M., Casey, S. J., Christie, D. L., Foreman, R. C., Hill, R. M., and Saunders, N. R., The complete cDNA and amino acid sequence of bovine fetuin. Its homology with α2-HS glycoprotein and relation to other members of the cystatin superfamily. J. Biol. Chem., 265, 4354-4357 (1990).
- . 1995. p. 103- 121.
- 48) Dickson, I. R., Poole, A. R., and Veis, A., Localization of plasma α2-HS glycoprotein in mineralizing human bone. Nature, 256, 430-432 (1975).
- 49) Ashton, B. A., Höling, H.-J., and Triffitt, J. T., Plasma proteins present in human cortical bone: Enrichment of the α2-HS glycoprotein. Calcif. Tissue Res., 22, 27-33 (1976).
- 50) Mbuyi, J.-M., Dequeker, J., Bloemmen, F., and Stevens, E., Plasma proteins in human cortical bone: Enrichment of α2-HS glycoprotein, α1 acid-glycoprotein, and IgE. Calcif. Tissue Int., 34, 229-231 (1982).
- 51) Pietschmann, P., Farsoudi, K. H., Hoffmann, O., Klaushofer, K., Hörandner, H., and Peterlik, M., Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria. Bone, 14, 167-172 (1993).
- 52) Perry, H. M., III and Gurbani, S., Development of monoclonal antibodies to parathyroid hormone induced resorptive factors from osteoblast-like cells. Calcif. Tissue Int., 50, 237-244 (1992).
- 53) Greenfield, E. M., Gornik, S. A., Horowitz, M. C., Donahue, H. J., and Shaw, S. M., Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J. Bone Miner. Res., 8, 1163-1171 (1993).
- 54) Nussbaum, S. R., Zahradnik, R. J., Lavigne, J. R., Brennam, G. L., Nozawa-Ung, K., Kim, L. Y., Keutmann, H. T., Wang, C. A., Potts, J. T., Jr, and Segre, G. V., Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin. Chem., 33, 1364-1367 (1987).
- . 1995. p. 11- 42.
- 56) Kessler, E. and Adar, R., Type I procollagen C-proteinase from mouse fibroblasts: purification and demonstration of a 55-kDa enhancer glycoprotein. Eur. J. Biochem., 186, 115-121 (1989).
- 57) Katunuma, N., Molecular mechanisms of bone collagen degradation in bone resorption. J. Bone Miner. Metab., 15, 1-8 (1997).
- 58) Tezuka, K., Tezuka, Y., Maejima, A., Sato, T., Nemoto, K., Kamioka, H., Hakeda, Y., and Kumegawa, M. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J. Biol. Chem., 269, 1106-1109 (1994).
- 59) Drake, F. H., Dodds, R. A., James, I. E., Connor, J. R., Debouck, C., Richrdson, S., Lee-Rykaczewski, E., Coleman, L., Rieman, D., Barthlow, R., Hastings, G., and Gowen, M., Cathepsin K, but not cathepsins B, L, or S, is abundently expressed in human osteoclasts. J. Biol. Chem., 271, 12511-12516 (1996).
- 60) Bossard, M. J., Tomaszek, T. A., Thompson, S. K., Amegadrizie, B. Y., Hanninng, C. R., Jones, C, Kurdyla, J. T., McMulty, D. E., Drake, F. H., Gowen, M., and Levy, M. A., Proteolytic activity of human osteoclast cathepsin K: expression, purification, activation, and substrate identification. J. Biol. Chem., 271, 12517-12524 (1996).
- 61) Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde, A., Rommerskirch, W., Moritz, J. D., Schu, P., and von Figura, K. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. U.S.A., 95, 13453-13458 (1998).
Full access
Effects of Rat Fetuin on Stimulation of Bone Resorption in the Presence of Parathyroid Hormone
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.